Wen-Han Cheng

Wen-Han Cheng

Auto-generated profile, based on publicly available information

Wen-Han Cheng

Division of Cardiology, Department of Internal Medicine, National Yang Ming Chiao Tung University Hospital , Yilan

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2018 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
WCWen‐Han Cheng
Wen‐Han Cheng
LLLi-Wei Lo
Li-Wei Lo
YLYenn‐Jiang Lin
Yenn‐Jiang Lin
CLChin-Yu Lin
Chin-Yu Lin
Yu-Feng HuYu-Feng Hu
Yu-Feng Hu
SCShih-Ann Chen
Shih-Ann Chen

17 March 2015 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
GSGwo-Ching Sun
Gwo-Ching Sun
WHWen‐Yu Ho
Wen‐Yu Ho
BCBo‐Rung Chen
Bo‐Rung Chen
PCPei-Wen Cheng
Pei-Wen Cheng
WCWen‐Han Cheng
Wen‐Han Cheng
CTChing‐Jiunn Tseng
Ching‐Jiunn Tseng
Background and Purpose: μ‐Opioid receptors, pro‐opiomelanocortin and pro‐enkephalin are highly expressed in the nucleus tractus solitarii (NTS) and μ receptor agonists given to the NTS dose‐dependently increased BP. However, the molecular mechanisms of this process remain unclear. In vitro, μ receptors heterodimerize with α2A‐adrenoceptors. We hypothesized that α2A‐adrenoceptor agonists would lose their depressor effects when their receptors heterodimerize in the NTS with μ receptors.Experimental Approach: We microinjected μ‐opioid agonists and antagonists into the NTS of rats and measured changes in BP. Formation of μ receptor/α2A‐adrenoceptor heterodimers was assessed with immunofluorescence and co‐immunoprecipitation methods, along with proximity ligation assays.Key Results: Immunofluorescence staining revealed colocalization of α2A‐adrenoceptors and μ receptors in NTS neurons. Co‐immunoprecipitation revealed interactions between α2A‐adrenoceptors and μ receptors. In situ proximity ligation assays confirmed the presence of μ receptor/α2A‐adrenoceptor heterodimers in the NTS. Higher levels of endogenous endomorphin‐1 and μ receptor/α2A‐adrenoceptor heterodimers were found in the NTS of hypertensive rats, than in normotensive rats. Microinjection of the μ receptor agonist [D‐Ala2, MePhe4, Gly5‐ol]‐enkephalin (DAMGO), but not that of the α2A‐adrenoceptor agonist guanfacine, into the NTS of normotensive rats increased μ receptor/α2A‐adrenoceptor heterodimer formation and BP elevation. The NO‐dependent BP‐lowering effect of α2A‐adrenoceptor agonists was blunted following increased formation of μ receptor/α2A‐adrenoceptor heterodimers in the NTS of hypertensive rats and DAMGO‐treated normotensive rats.Conclusions and Implications: Increases in endogenous μ receptor agonists in the NTS induced μ receptor/α2A‐adrenoceptor heterodimer formation and reduced the NO‐dependent depressor effect of α2A‐adrenoceptor agonists. This process could contribute to the pathogenesis of hypertension.

25 September 2020 in Circulation Journal
Verified
Journal Article
Open access
PDF file
Yu-Feng HuYu-Feng Hu
Yu-Feng Hu
WCWen-Han Cheng
Wen-Han Cheng
YHYuan Hung
Yuan Hung
WLWen-Yu Lin
Wen-Yu Lin
TCTze-Fan Chao
Tze-Fan Chao
SCShih-Ann Chen
Shih-Ann Chen
The health crisis due to coronavirus disease 2019 (COVID-19) has shocked the world, with more than 1 million infections and casualties. COVID-19 can present from mild illness to multi-organ involvement, but especially acute respiratory distress syndrome. Cardiac injury and arrhythmias, including atrial fibrillation (AF), are not uncommon in COVID-19. COVID-19 is highly contagious, and therapy against the virus remains premature and largely unknown, which makes the management of AF patients during the pandemic particularly challenging. We describe a possible pathophysiological link between COVID-19 and AF, and therapeutic considerations for AF patients during this pandemic.

Verified
Journal Article
Open access
PDF file
CLCheng-Hung Li
Cheng-Hung Li
LLLi-Wei Lo
Li-Wei Lo
AJAnkit Jain
Ankit Jain
YHYu-Cheng Hsieh
Yu-Cheng Hsieh
LYLin Yenn-jiang
Lin Yenn-jiang
SCShih-Ann Chen
Shih-Ann Chen
Background: Atypical atrial flutter (aAFL) is not uncommon, especially after a prior cardiac surgery or extensive ablation in atrial fibrillation (AF). Aims: To revisit aAFL, we used a novel Lumipoint algorithm in the Rhythmia mapping system to evaluate tachycardia circuit by the patterns of global activation histogram (GAH, SKYLINE) in assisting aAFL ablation. Methods: Fifteen patients presenting with 20 different incessant aAFL, including two naïve, six with a prior AF ablation, and seven with prior cardiac surgery were studied. Results: Reentry aAFL in SKYLINE typically was a multi-deflected peak with 1.5 GAH-valleys. Valleys were sharp and narrow-based. Most reentry aAFL (18/20, 90%) lacked a plateau and displayed a steep GAH-valley with 2 GAH-valleys per tachycardia. Each GAH-valley highlighted 1.9 areas in the map. Successful sites of ablation all matched one of the highlighted areas based on GAH-valleys < 0.4. These sites corresponded with the areas highlighted by GAH-score < 0.4 in reentry aAFL, and by GAH-score < 0.2 in localized-reentry aAFL. Conclusions: The present study showed benefits of the LumipointTM module applied to the RhythmiaTM mapping system. The results were the efficient detection of the slow conduction, better identification of ablation sites, and fast termination of the aAFL with favorable outcomes.

19 February 2026 in EP Europace
Verified
Journal Article
Open access
YCYI-HSIN CHAN
YI-HSIN CHAN
YKYi-Wei Kao
Yi-Wei Kao
WCWen-Han Cheng
Wen-Han Cheng
SCShao-Wei Chen
Shao-Wei Chen
Chung-Lieh HungChung-Lieh Hung
Chung-Lieh Hung
TCTze-Fan Chao
Tze-Fan Chao
Aims: Cardiovascular-kidney-metabolic (CKM) syndrome reflects the interplay of cardiovascular disease (CVD), chronic kidney disease (CKD), and metabolic risk factors. We examined whether the number, components, and complexity of CKM domains influence outcomes and years of life lost (YLL) per death in patients with non-valvular atrial fibrillation (AF) receiving direct oral anticoagulants (DOACs). Methods and results: We included 17 378 AF patients (mean age 76.1 ± 10.7 years; 40.9% women) on DOACs from a multicentre Taiwanese database (2012–21). Patients were followed until outcomes, death, or study end. Overall, 18.1, 35.1, 32.2, and 14.6% of patients had 0, 1, 2, and 3 CKM domains. Women more often exhibited kidney, metabolic, or combined domains. Clinical risks rose stepwise with domain number; patients with three domains had the highest risks of ischaemic stroke/systemic embolic event/acute coronary syndrome (IS/SEE/ACS) [adjusted hazard ratio (aHR) 1.60, 95% confidence interval (CI) 1.25–2.05], major bleeding (aHR 2.60, 95% CI 2.00–3.38), heart failure hospitalization (aHR 2.83, 95% CI 2.38–3.37), all-cause mortality (aHR 1.80, 95% CI 1.58–2.06), acute kidney injury (aHR 3.42, 95% CI 2.76–4.25), and major adverse renal events (aHR 20.84, 95% CI 14.14–30.71; all P < 0.001). Domain-specific analysis showed kidney involvement conferred the strongest risks (except IS/SEE/ACS), while cardiovascular and metabolic domains were more associated with IS/SEE/ACS. YLL rose with more CKM domains, with females associated with greater reductions, especially in cardiovascular (−10.29 vs. −4.67) and metabolic (−4.98 vs. −0.80) domains (P < 0.001). Conclusion: Increasing CKM burden was associated with progressively worse prognosis and shorter life expectancy in AF patients on DOACs, with more pronounced impacts in women.

1 May 2021 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
PDF file
CLChin-Yu Lin
Chin-Yu Lin
LYLin Yenn-jiang
Lin Yenn-jiang
Men-Tzung LoMen-Tzung Lo
Men-Tzung Lo
CCChia-Hsin Chiang
Chia-Hsin Chiang
Yun-Yu ChenYun-Yu Chen
Yun-Yu Chen
SCShih-Ann Chen
Shih-Ann Chen